DL-methionine sulfoximine, with the CAS number 1982-67-8, is a sulfoximine derivative of the amino acid methionine. It is characterized by the presence of a sulfoximine functional group, which consists of a sulfur atom bonded to both an oxygen atom and a nitrogen atom. This compound is typically a white crystalline solid and is soluble in water, making it suitable for various applications in biochemistry and agriculture. DL-methionine sulfoximine is known for its role as an inhibitor of the enzyme asparagine synthetase, which can affect amino acid metabolism. Additionally, it has been studied for its potential use in enhancing plant growth and stress resistance, as well as its implications in neurobiology due to its effects on neurotransmitter synthesis. The compound's stability and reactivity are influenced by its functional groups, making it a subject of interest in both synthetic and applied chemistry. Safety data should be consulted for handling and usage, as with any chemical substance.

dl-methionine sulfoximine

1982-67-8: (2R)-2-amino-4-(S-methylsulfonimidoyl)butanoic acid, 2-Amino-4-(Methylsulfonimidoyl)Butanoic Acid, 2-Amino-4-(S-methylsulfonimidoyl)butanoic acid, 2-Amino-4-(S-methylsulphonimidoyl)butyric acid, 2-Amino-4-[imino(methyl)oxo-λ6-sulfanyl]butanoic acid, 2-Azaniumyl-4-(methylsulfonimidoyl)butanoate, <span class="text-smallcaps">DL</smallcap>-Methionine-<smallcap>DL</span>-sulfoximine, Ai3-62723, Butanoic acid, 2-amino-4-(S-methylsulfonimidoyl)-, Ccris 5096, DL-Methionine-DL-sulfoximine, Methionine sulfoximine, Methionine-DL-sulfoximine, DL-, Methionine-RS-sulfoximine, L-, Sulfoximine, S-(3-amino-3-carboxypropyl)-S-methyl-, <span class="text-smallcaps">DL</span>-, Sulfoximine, S-(3-amino-3-carboxypropyl)-S-methyl-, DL-

DL-Methionine sulfoximine is a drug that blocks the synthesis of glutathione, an important antioxidant and detoxifying agent. DL-Methionine sulfoximine may be useful in preventing or treating eye disorders, such as age-related macular degeneration and retinitis pigmentosa. It also has been shown to have beneficial effects in animal models of epilepsy, Alzheimer’s disease, Parkinson's disease, and stroke. DL-Methionine sulfoximine has been shown to have beneficial effects in animal models of epilepsy, Alzheimer’s disease, Parkinson's disease, and stroke. This drug is being studied for its potential use in metabolic disorders such as diabetes and obesity.

DL-Methionine-DL-sulfoximine

Methionine sulfoximine (MSO) is an irreversible glutamine synthetase inhibitor. It is the sulfoximine derivative of methionine with convulsant effects.

CAS 1982-67-8: dl-methionine sulfoximine

DL-Methionine-DL-sulfoximine

Ref: 3D-FM57660

Methionine sulfoximine

Ref: TM-T70016